Tofacitinib Impurity 36

Request For Quotation
Tofacitinib Impurity 36 Suppliers list
Company Name: Wuxi Zhongkun Biochemical Technology Co., Ltd.  
Tel: 0510-85629785 18013409632;
Email: sales@reading-chemicals.com
Company Name: Jinan SanZhi Pharmaceutical Technology Co., Ltd.  
Tel: 15053191807
Email: sales_sanzhi@163.com
Company Name: Shanghai Changyan Chem & Tech Co., Ltd.  
Tel: 021-20242659 18930833303
Email: sales@changyanchem.cn
Company Name: Shenzhen SUNGENING Bio-Medical Co., Ltd.  
Tel: 0755-28967200 13631290199
Email: wxf@sungening.com
Company Name: ANHUI WITOP BIOTECH CO., LTD  
Tel: +8618071025641
Email: eric@witopchemical.com
Tofacitinib Impurity 36 Basic information
Product Name:Tofacitinib Impurity 36
Synonyms:Tofacitinib Impurity 36;Tofacitinib Impurity 219;7-Tosyl-3H-pyrrolo[2,3-d]pyrimidin-4(7H)-one;4H-Pyrrolo[2,3-d]pyrimidin-4-one, 3,7-dihydro-7-[(4-methylphenyl)sulfonyl]-;7-Tosyl-3H-pyrrolo[2,3-d]pyrimidin-4(7H)-one (Tofacitinib Impurity);3,7-dihydro-7-[(4-methylphenyl)sulfonyl]-4H-Pyrrolo[2,3-d]pyrimidin-4-one
CAS:2250241-69-9
MF:C13H11N3O3S
MW:289.31
EINECS:
Product Categories:
Mol File:2250241-69-9.mol
Tofacitinib Impurity 36 Structure
Tofacitinib Impurity 36 Chemical Properties
Boiling point 540.0±60.0 °C(Predicted)
density 1.49±0.1 g/cm3(Predicted)
pka0.90±0.20(Predicted)
Safety Information
MSDS Information
Tofacitinib Impurity 36 Usage And Synthesis
Tofacitinib Impurity 36 Preparation Products And Raw materials
Tag:Tofacitinib Impurity 36(2250241-69-9) Related Product Information
(3R,4R)-N,1,4-trimethyl-N-{7H-pyrrolo[2,3-d]pyrimidin-4-yl}piperidin-3-amine N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine Tofacitinib Impurity 6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine 7H-Pyrrolo[2,3-d]pyriMidin-4-aMine, N-Methyl-N-[(3R,4R)-4-Methyl-1-(phenylMethyl)-3-piperidinyl]-7-[(4-Met hylphenyl)sulfonyl]- 1-Piperidinepropanoic acid, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, ethyl ester, (3R,4R)- 3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide 3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine Tofacitinib Impurity butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate 3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI) N-(2,6-dimethylphenyl)-2-((2,6-dimethylphenyl)amino)acetamide (3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine Tofacitinib Related Compound Tofacitinib Impurity 45 Tofacitinib Impurity 2 1-Benzyl-n,4-dimethylpiperidin-3-amine dihydrochloride